RBx10080307, a dual EGFR/IGF-1R inhibitor for anticancer therapy.
Tandon R, Senthil V, Nithya D, Pamidiboina V, Kumar A, Malik S, Chaira T, Diwan M, Gupta P, Venkataramanan R, Malik R, Das B, Dastidar SG, Cliffe I, Ray A, Bhatnagar PK.
Tandon R, et al. Among authors: dastidar sg.
Eur J Pharmacol. 2013 Jul 5;711(1-3):19-26. doi: 10.1016/j.ejphar.2013.04.016. Epub 2013 Apr 29.
Eur J Pharmacol. 2013.
PMID: 23639757